GLP-1GIP chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1

This publication has 20 references indexed in Scilit:

• Gastric inhibitory polypeptide receptor, a member of the secretin- vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain
  Endocrinology, 1993
• Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7–36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells
  Journal of Molecular Endocrinology, 1993
• Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations
  Journal of Clinical Endocrinology & Metabolism, 1993
• Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
  Journal of Clinical Investigation, 1993
• Glucagon-like peptide-1(7–36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells
  Journal of Molecular Endocrinology, 1990
• Characterization of the receptor for glucagon-like peptide-1(7–36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking
  Journal of Molecular Endocrinology, 1989
• Gastric inhibitory polypeptide receptor in hamster pancreatic beta cells. Direct cross-linking, solubilization and characterization as a glycoprotein
  European Journal of Biochemistry, 1986
• Structural requirements for gastric inhibitory polypeptide (GIP) receptor binding and stimulation of insulin release
  Peptides, 1986
• Functional GIP receptors in a hamster pancreatic beta cell line, In 111: Specific binding and biological effects
  Biochemical and Biophysical Research Communications, 1984
• The incretin concept today
  Diabetologia, 1979